Grant ID

12T-010

Illness

schizophrenia

Primary Drug/Intervention

famotidine

Primary Dosage

N/A

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Cancelled

Investigator

Tiihonen

Sample Size

140

Duration of Study Period for Each Subject

56 days

Outcome Measurements

N/A

Results

N/A

Publication

N/A

Link

N/A

PI Name

Jari Tiihonen

Degree

MD

Center

N/A

Institution

Karolinska Institutet

Address

City or Town

N/A

State or Province

N/A

Zip or Postal Code

N/A

Country

Sweden

Email Address

jari.tiihonen@ki.se